SCHEMBL21614715

SCHEMBL21614715

Fc1ccc(Oc2ccc(-c3nc(CNc4ccnc(C(F)(F)F)c4)cs3)cn2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 2/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ ABCB1 P08183 1/20 0.42
▸ ABCG2 Q9UNQ0 1/20 0.42
▸ TP53 P04637 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ CYP2C9 P11712 1/20 0.39
▸ POLB P06746 2/20 0.38
▸ ATM Q13315 1/20 0.38
▸ IDH1 O75874 1/20 0.38
▸ SCN9A Q15858 4/20 0.37
▸ GRM5 P41594 1/20 0.35
▸ RHOC P08134 1/20 0.35
▸ RHOA P61586 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ FPR2 P25090 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21612036 0.91 CYP2C19 (0.52) CYP2C19CYP3A4TP53MAPTCYP2C9
SCHEMBL21612013 0.83 CYP2C19 (0.61) CYP2C19CYP3A4TP53MAPTCYP2C9
SCHEMBL21614717 0.81 TP53 (0.50) CYP2C19CYP3A4TP53MAPTCYP2C9
SCHEMBL21614721 0.79 CYP2C19 (0.51) CYP2C19CYP3A4TP53MAPTCYP2C9
SCHEMBL21614728 0.78 CYP2C19 (0.57) CYP2C19CYP3A4TP53MAPTCYP2C9
SCHEMBL21612043 0.77 CYP2C19 (0.56) CYP2C19CYP3A4CYP2C9SCN9AHDAC1
SCHEMBL21614716 0.75 CYP2C19 (0.48) CYP2C19CYP3A4TP53MAPTCYP2C9
SCHEMBL21614718 0.75 SYK (0.42) CYP2C19CYP3A4ABCB1ABCG2TP53
SCHEMBL21612023 0.75 IDH1 (0.46) CYP2C19CYP3A4MAPTCYP2C9IDH1
SCHEMBL21614660 0.71 CYP2C19 (0.63) CYP2C19CYP3A4CYP2C9SCN9AHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210353606-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-11-18 — — US disclosed
WO-2020007938-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2020-01-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210353606-A1 PqsR INVERSE AGONISTS QRFPR, P2RY11, QARS1 CYP2C19 1824/4885CYP3A4 3080/4885ABCB1 1105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback